Related Experiment Video
Updated: Apr 14, 2026
Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Endothelial cells regulate mesangial cells through the Dll4/Notch3 axis to participate in glomerular injury in lupus
Haixia Guo1,2, Yueying Mao1, Yongjun Wang3
1Department of Rheumatology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, China.
Introduction:
Increasing evidence suggests that microvascular dysregulation mediates mesangial cell (MC) alteration in the pathogenesis of LN (Lupus nephritis). However, the heterogeneity of endothelial cells (ECs) in LN and their regulatory mechanisms on MCs have not been thoroughly investigated.
Objective:
To elucidate the regulatory role and mechanism of ECs in the development and progression of LN.
Methods:
We analyzed EC heterogeneity and cell-cell interactions in the kidneys of LN mice using single-nucleus RNA sequencing (snRNA-seq). In vitro, MCs were treated with Dll4 protein or the Notch3 inhibitor (Tarextumab) to detect the effects of Dll4/Notch3 axis on MCs. Then, in an EC and MC co-culture system, we interfered Dll4 in ECs or added Tarextumab in MCs to confirm that ECs can secret Dll4 to regulate MCs by Notch3 pathway after LPS stimulation. ELISA and immunohistochemical staining were performed on clinical blood samples and renal biopsies, respectively, to compare Dll4 expression levels between systemic lupus erythematosus (SLE) patients without LN (non-renal SLE) and those with LN.
Results:
We found that the number of ECs was increased during LN process and ECs exhibited cellular heterogeneity, among which EC subcluster EC-1 was identified as a potential regulator of MCs, possibly through the Dll4/Notch3 axis. In vitro experiments showed that Dll4 can promote the proliferation and migration of MC through Notch3. Interfering Dll4 in ECs or administering a Notch3 inhibitor (Tarextumab) in MC can significantly inhibit the effects on MC. Clinically, we analyzed peripheral blood and kidney tissues from non-renal SLE and LN patients and confirmed that Dll4 expression correlated with the disease activity of LN.
Conclusions:
Our findings suggest that abnormal EC activation may be associated with LN progression, potentially through promoting MC migration and proliferation via the Dll4/Notch3 axis. This study reveals a candidate molecular axis in the progression of LN and provides preliminary preclinical insights for future investigation into therapeutic strategies in LN.
Insights
Endothelial cells (ECs) play a role in Lupus nephritis (LN) progression by influencing mesangial cells (MCs) via the Dll4/Notch3 pathway. Targeting this axis may offer new therapeutic strategies for LN.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Microvascular dysregulation is implicated in Lupus nephritis (LN) pathogenesis.
- Endothelial cell (EC) heterogeneity and their regulatory roles in LN remain under-investigated.
Purpose of the Study:
- To investigate the regulatory role and molecular mechanisms of ECs in LN development and progression.
- To elucidate the specific EC subtypes and their interactions with mesangial cells (MCs) in LN.
Main Methods:
- Single-nucleus RNA sequencing (snRNA-seq) to analyze EC heterogeneity and cell-cell interactions in LN mouse kidneys.
- In vitro studies using MCs treated with Dll4 or Notch3 inhibitor (Tarextumab).
- EC and MC co-culture systems with Dll4 interference in ECs or Tarextumab in MCs.
- ELISA and immunohistochemical staining on human samples (SLE patients without LN vs. LN patients).
Main Results:
- Increased EC numbers and identified a specific EC subcluster (EC-1) potentially regulating MCs via the Dll4/Notch3 axis.
- Dll4 promoted MC proliferation and migration in vitro, which was inhibited by Dll4 interference or Notch3 inhibition.
- Elevated Dll4 expression in LN patients correlated with disease activity.
Conclusions:
- Abnormal EC activation, particularly via the Dll4/Notch3 axis, may drive LN progression by promoting MC migration and proliferation.
- This study identifies a potential molecular axis for LN progression and suggests therapeutic targets for LN treatment.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:28Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
01:05Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...